Nutex Health (NASDAQ:NUTX) Cut to “Hold” at Wall Street Zen
by Sarita Garza · The Markets DailyWall Street Zen downgraded shares of Nutex Health (NASDAQ:NUTX – Free Report) from a buy rating to a hold rating in a research note published on Saturday,Wall Street Zen reports.
A number of other research analysts have also recently issued reports on the company. B. Riley Financial boosted their target price on Nutex Health from $290.00 to $325.00 and gave the company a “buy” rating in a research note on Friday. Lake Street Capital reiterated a “buy” rating and set a $310.00 price objective (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. B Riley reissued a “buy” rating on shares of Nutex Health in a research note on Friday. Finally, Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Nutex Health has a consensus rating of “Buy” and an average price target of $317.50.
Read Our Latest Stock Report on NUTX
Nutex Health Price Performance
Shares of NASDAQ NUTX opened at $193.24 on Friday. Nutex Health has a 52-week low of $80.53 and a 52-week high of $204.00. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. The stock has a market cap of $1.32 billion, a P/E ratio of 7.59 and a beta of 0.28. The firm has a 50 day moving average price of $176.11 and a 200 day moving average price of $137.66.
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The company had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. California State Teachers Retirement System lifted its position in shares of Nutex Health by 25,615.8% in the second quarter. California State Teachers Retirement System now owns 934,768 shares of the company’s stock valued at $159,743,000 after buying an additional 931,133 shares during the last quarter. BlackRock Inc. acquired a new position in shares of Nutex Health during the 2nd quarter worth approximately $69,612,000. Topline Capital Management LLC raised its stake in Nutex Health by 72.0% in the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock valued at $38,484,000 after acquiring an additional 129,418 shares during the period. Winmill & CO. Inc. bought a new position in Nutex Health during the second quarter worth $11,168,000. Finally, Millennium Management LLC increased its holdings in shares of Nutex Health by 191.1% in the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after purchasing an additional 61,308 shares during the last quarter. 5.32% of the stock is currently owned by institutional investors.
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
See Also
- Five stocks we like better than Nutex Health
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane